Keita Idemoto

Sodegaura, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Neural substrates of treatment-resistant schizophrenia and the response to clozapine: A structural MRI study in a clinical setting.

Neural substrates of treatment-resistant schizophrenia and the response to clozapine: A structural MRI study in a clinical setting.

Journal: PloS one

Published: September 25, 2025

A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report.

A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report.

Journal: Neuropsychopharmacology reports

Published: March 29, 2025

Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia.

Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia.

Journal: Frontiers in psychiatry

Published: November 07, 2023

Association between precautionary behaviors against coronavirus disease and psychosocial factors in outpatients with a pre-existing disease and their attendants.

Association between precautionary behaviors against coronavirus disease and psychosocial factors in outpatients with a pre-existing disease and their attendants.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: December 27, 2022

Risk factors for early-phase clozapine discontinuation: A nested case-control study.

Risk factors for early-phase clozapine discontinuation: A nested case-control study.

Journal: Asian journal of psychiatry

Published: February 18, 2021

Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.

Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.

Journal: Psychiatry research

Published: October 02, 2020

Association between serum levels of glial cell line-derived neurotrophic factor and inattention in adult patients with attention deficits/hyperactivity disorder.

Association between serum levels of glial cell line-derived neurotrophic factor and inattention in adult patients with attention deficits/hyperactivity disorder.

Journal: Psychiatry research

Published: September 27, 2020

Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparison.

Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparison.

Journal: Annals of general psychiatry

Published: September 13, 2020

Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.

Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.

Journal: Journal of psychiatric research

Published: August 09, 2020

Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan.

Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan.

Journal: Brain, behavior, & immunity - health

Published: May 14, 2020

Clozapine-induced myocarditis: Follow-up for 3.5 years after successful retrial.

Clozapine-induced myocarditis: Follow-up for 3.5 years after successful retrial.

Journal: Journal of general and family medicine

Published: June 20, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026